Analysis of epidemiological serosurvey of hepatitis B virus among people under 29 years of age in Jiangsu Province, China

References

• Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156(2):477–91 e1. doi:10.1053/j.gastro.2018.08.065.
   PubMed Web of Science ®Google Scholar
• Zhou KN, Zhang M, Wu Q, Ji ZH, Zhang XM, Zhuang GH. Psychometrics of chronic liver disease questionnaire in Chinese chronic hepatitis B patients. World J Gastroenterol. 2013;19:3494–501. doi:10.3748/wjg.v19.i22.3494.
   PubMed Web of Science ®Google Scholar
• Liao X, Liang Z. Strategy vaccination against Hepatitis B in China. Hum Vaccin Immunother. 2015;11:1534–39.
   PubMed Web of Science ®Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Reprint of: epidemiological serosurvey of Hepatitis B in China–declining HBV prevalence due to Hepatitis B vaccination. Vaccine. 2013;31(Suppl 9):J21–8. doi:10.1016/j.vaccine.2013.08.012.
   PubMed Web of Science ®Google Scholar
• Wang FZ, Cui FQ. The immunoprophylaxis strategy of prevention mother to child transmission of hepatitis B virus (in Chinese). Chin J Vaccines Immunization. 2014;20:355–59.
   Google Scholar
• Wang FZ, Zhang GM, Shen LP, Zheng H, Wang F, Miao N, Yuan QL, Sun XJ, Bi SL, Liang XF, et al. Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014. Zhonghua Yu Fang Yi Xue Za Zhi [Chin J Preventive Med]. 2017;51:462–68. doi:10.3760/cma.j..0253-9624.2017.06.002.
   PubMedGoogle Scholar
• Huang P, Zhu LG, Zhu YF, Yue M, Su J, Zhu FC, Yang HT, Zhang Y, Shen HB, Yu RB, et al. Seroepidemiology of hepatitis B virus infection and impact of vaccination. World J Gastroenterol. 2015;21:7842–50. doi:10.3748/wjg.v21.i25.7842.
   PubMed Web of Science ®Google Scholar
• Wang ZG, Ma FB, Tang FY. Investigation on epidemic situation of hepatitis B virus and vaccination among children in Jiangsu province. Chinese J Public Health. 2009;25:483–85.
   Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27:6550–57. doi:10.1016/j.vaccine.2009.08.048.
   PubMed Web of Science ®Google Scholar
• Wang F, Shen L, Cui F, Zhang S, Zheng H, Zhang Y, Liang X, Wang F, Bi S. The long-term efficacy, 13-23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China. Vaccine. 2015;33:2704–09. doi:10.1016/j.vaccine.2015.03.064.
   PubMed Web of Science ®Google Scholar
• Cui Y, Jia J. Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol. 2013;28(Suppl 1):7–10. doi:10.1111/jgh.12220.
   PubMed Web of Science ®Google Scholar
• Guo-Liang Xia C-BL, Cao H-L. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol. 1996;5:62–73.
   Google Scholar
• Wang S, Tao Y, Tao Y, Jiang J, Yan L, Wang C, Ding Y, Yu J, Zhao D, Chi X. Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional study. BMC Public Health. 2018;18(1):1088. doi:10.1186/s12889-018-5984-6.
   PubMed Web of Science ®Google Scholar
• Chen P, Yu C, Ruan B, Yang S, Ren J, Xu W, Luo Z, Li L. Prevalence of hepatitis B in insular regions of southeast China: a community-based study. PloS One. 2013;8(2):e56444. doi:10.1371/journal.pone.0056444.
   PubMed Web of Science ®Google Scholar
• Zhou Y, He H, Deng X, Yan R, Tang X, Xie S, Yao J. Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014. Vaccine. 2017;35:4355–61. doi:10.1016/j.vaccine.2017.06.078.
   PubMed Web of Science ®Google Scholar
• Ma JC, Wu ZW, Zhou HS, Gao Z, Hao ZY, Jin F, Zhang Y-H, Li M-J, Wang F, Li Q. Long-term protection at 20-31 years after primary vaccination with plasma-derived hepatitis B vaccine in a Chinese rural community. Hum Vaccin Immunother. 2020;16:16–20. doi:10.1080/21645515.2019.1646575.
   PubMed Web of Science ®Google Scholar
• Li H, Li GJ, Chen QY, Fang ZL, Wang XY, Tan C, Yang QL, Wang FZ, Wang F, Zhang S, et al. Long-term effectiveness of plasma-derived hepatitis B vaccine 22-28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed? Epidemiol Infect. 2017;145:887–94. doi:10.1017/S0950268816003046.
   PubMed Web of Science ®Google Scholar
• Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000–summary of a workshop. Gastroenterology. 2001;120:1828–53. doi:10.1053/gast.2001.24839.
   PubMed Web of Science ®Google Scholar
• Yonghao G, Jin X, Jun L, Pumei D, Ying Y, Xiuhong F, Yanyang Z, Wanshen G. An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China. Int J Infect Dis. 2015;40:75–80. doi:10.1016/j.ijid.2015.10.002.
   PubMed Web of Science ®Google Scholar
• Da Villa G, Romanò L, Sepe A, Iorio R, Paribello N, Zappa A, Zanetti AR. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine. 2007;25(16):3133–36. doi:10.1016/j.vaccine.2007.01.044.
   PubMed Web of Science ®Google Scholar
• Creati M, Saleh A, Ruff TA, Stewart T, Otto B, Sutanto A, Clements CJ. Implementing the birth dose of hepatitis B vaccine in rural Indonesia. Vaccine. 2007;25(32):5985–93. doi:10.1016/j.vaccine.2007.05.055.
   PubMed Web of Science ®Google Scholar
• Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst Rev. 2006;CD004790. doi:10.1002/14651858.CD004790.pub2.
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Mariano A, Romanò L, D’Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet (London, England). 2005;366(9494):1379–84. doi:10.1016/S0140-6736(05)67568-X.
   PubMed Web of Science ®Google Scholar